Characterization and manipulation of the acyl chain selectivity of fatty acid amide hydrolase

被引:56
作者
Patricelli, MP
Cravatt, BF
机构
[1] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA
[2] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA
关键词
D O I
10.1021/bi002578r
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Fatty acid amide hydrolase (FAAH) is a mammalian integral membrane enzyme that catabolizes several neuromodulatory fatty acid amides, including the endogenous cannabinoid anandamide and the sleep-inducing lipid oleamide. FAAH belongs to a large group of hydrolytic enzymes termed the amidase signature (AS) family that is defined by a conserved, linear AS sequence of approximately 130 amino acids. Members of the AS family display strikingly different substrate selectivities, yet the primary structural regions responsible for defining substrate recognition in these enzymes remain unknown. In this study, a series of unbranched p-nitroanilide (pNA) substrates ranging from 6 to 20 carbons in length was used to probe the acyl chain binding specificity of FAAH, revealing that this enzyme exhibits a strong preference for acyl chains 9 carbons in length or longer. A fluorophosphonate inhibitor of FAAH containing a photoactivatable benzophenone group was synthesized and used to locate a region of the enzyme implicated in substrate binding. Protease digestion and mass spectrometry analysis of FAAH-inhibitor conjugates identified the major site of cross-linking as residues 487-493. Site-directed mutagenesis revealed that a single residue in this region, 1491, strongly influenced substrate specificity of FAAH. For example, an I491A mutant displayed a greatly reduced binding affinity for medium-chain pNA substrates (7-12 carbons) but maintained nearly wild-type binding and catalytic constants for longer chain substrates (14-20 carbons). Mutation of 1491 to aromatic or more polar residues generated enzymes with relative hydrolytic efficiencies for medium versus long-chain pNAs that varied up to 90-fold. Collectively, these studies indicate that 1491 participates in hydrophobic binding interactions with medium-chain FAAH substrates. Additionally, the significant changes in substrate selectivity achieved by single amino acid changes suggest that FAAH possesses a rather malleable substrate binding domain and may serve, along with other AS enzymes, as a template for the engineering of amidases with novel and/or tailored specificities.
引用
收藏
页码:6107 / 6115
页数:9
相关论文
共 54 条
  • [1] IDENTIFICATION OF FATTY-ACID AMIDES IN HUMAN-PLASMA
    ARAFAT, ES
    TRIMBLE, JW
    ANDERSEN, RN
    DASS, C
    DESIDERIO, DM
    [J]. LIFE SCIENCES, 1989, 45 (18) : 1679 - 1687
  • [2] Characterization of the hypnotic properties of oleamide
    Basile, AS
    Hanus, L
    Mendelson, WB
    [J]. NEUROREPORT, 1999, 10 (05) : 947 - 951
  • [3] Exceptionally potent inhibitors of fatty acid amide hydrolase: The enzyme responsible for degradation of endogenous oleamide and anandamide
    Boger, DL
    Sato, H
    Lerner, AE
    Hedrick, MP
    Fecik, RA
    Miyauchi, H
    Wilkie, GD
    Austin, BJ
    Patricelli, MP
    Cravatt, BF
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (10) : 5044 - 5049
  • [4] Structural requirements for 5-HT2A and 5-HT1A serotonin receptor potentiation by the biologically active lipid oleamide
    Boger, DL
    Patterson, JE
    Jin, Q
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (08) : 4102 - 4107
  • [5] Trifluoromethyl ketone inhibitors of fatty acid amide hydrolase: A probe of structural and conformational features contributing to inhibition
    Boger, DL
    Sato, H
    Lerner, AE
    Austin, BJ
    Patterson, JE
    Patricelli, MP
    Cravatt, BF
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (02) : 265 - 270
  • [6] Boger DL, 1998, CURR PHARM DESIGN, V4, P303
  • [7] Purification, gene cloning, targeted knockout, overexpression, and biochemical characterization of the major pyrazinamidase from Mycobacterium smegmatis
    Boshoff, HIM
    Mizrahi, V
    [J]. JOURNAL OF BACTERIOLOGY, 1998, 180 (22) : 5809 - 5814
  • [8] Cadas H, 1997, J NEUROSCI, V17, P1226
  • [9] Study of the amidase signature group
    Chebrou, H
    Bigey, F
    Arnaud, A
    Galzy, P
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY, 1996, 1298 (02): : 285 - 293
  • [10] REDESIGNING TRYPSIN - ALTERATION OF SUBSTRATE-SPECIFICITY
    CRAIK, CS
    LARGMAN, C
    FLETCHER, T
    ROCZNIAK, S
    BARR, PJ
    FLETTERICK, R
    RUTTER, WJ
    [J]. SCIENCE, 1985, 228 (4697) : 291 - 297